(Q73230385)
Statements
Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats (English)
1 reference
14 December 2021
J K Callaway
M J Knight
D J Watkins
P M Beart
2704-12; discussion 2712